Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension

Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia

(2011) D. Dumitrescu et al.   EUROPEAN RESPIRATORY JOURNAL

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

(2011) Jan K Hennigs et al.   BMC Pulmonary Medicine

Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats

(2010) R. Dumitrascu et al.   EUROPEAN RESPIRATORY JOURNAL

Targeting non-malignant disorders with tyrosine kinase inhibitors

(2010) Friedrich Grimminger et al.   NATURE REVIEWS DRUG DISCOVERY

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

(2010) Hagop Kantarjian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

(2009) Kurt R. Stenmark et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension

(2009) Bhola Kumar Dahal et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents

(2009) Mohamed Izikki et al.   JOURNAL OF CLINICAL INVESTIGATION

Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension

(2008) Frédéric Perros et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient

(2008) D Mattei et al.   BONE MARROW TRANSPLANTATION

Role of src-family kinases in hypoxic vasoconstriction of rat pulmonary artery

(2008) Greg A. Knock et al.   CARDIOVASCULAR RESEARCH

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

(2008) Alfiya Akhmetshina et al.   FASEB JOURNAL

Molecular pathogenesis of pulmonary arterial hypertension

(2008) Marlene Rabinovitch   JOURNAL OF CLINICAL INVESTIGATION

Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib

(2008) Oliver Hantschel et al.   LEUKEMIA & LYMPHOMA

Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia

(2008) Walid Rasheed et al.   LEUKEMIA RESEARCH